APPLICATION
ANDA077846
TYPE
ANDA
ORIGINAL APPROVAL
2008-10-28
LATEST ACTION
2021-12-03
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Discontinued
Products
DORZOLAMIDE HYDROCHLORIDEDiscontinued
DORZOLAMIDE HYDROCHLORIDE EQ 2% BASE · SOLUTION/DROPS · OPHTHALMIC
Approval history
2021-12-03Labeling · Supplement 11 · standardAP
2015-04-06Labeling · Supplement 5 · standardAP
2011-01-25Labeling · Supplement 2AP
2009-03-06Labeling · Supplement 1AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.